Back to Ask the Diabetes Team Ask the Diabetes Team

From Jackson, Mississippi, USA:

My daughter has had Type 1 diabetes since the age of 10 months. At the age of 12 her doctor found high levels of thyroid antibodies. If low dose L-thyroxine treatment is begun early with the detection of high levels of thyroid antibodies, how great is the likelihood of halting the autoimmune process? I am looking for percentages.


The association of thyroid problems with diabetes has long been acknowledged; but it has been only in the last few years that they have been recognised as the two most common components of the Autoimmune Polyglandular Syndrome Type II. Celiac disease and adrenocortical insufficiency are the next most common and there are many others. The intricacies of the autoimmune process in relation to the thyroid gland have been far less extensively explored than for the beta cells in the pancreas. In part this is because many centers still depend on a rise in the TSH (Thyroid Stimulating Hormone) rather than a thyroid antibody test for diagnosis and in part because treatment is so straightforward and free of complications. From such evidence as there is though, your daughter is likely to need treatment for the rest of her life and antibodies will persist.


Original posting 2 May 2000
Posted to Thyroid


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.